Caylis Pro® LAL System for Biomechanical and Physiological Responses in Lying Postures
This study aims to evaluate the effects of the Caylis Pro LAL System on the biomechanical and physiological responses of individuals in lying postures, focusing on prevention.
CLP and pulsation
Prevention Study
Summary
Study start date: September 30, 2025
Actual date on which the first participant was enrolled.This study is designed to explore how the body responds when lying down for long periods using a new type of mattress system called the Caylis Pro® Low Air Loss (LAL) System. The focus is on understanding how the mattress affects the pressure on the body and blood flow in small blood vessels during these long periods of rest. This research is important as it could lead to better care for people who have to stay in bed for extended times, helping to improve comfort and prevent issues like pressure sores. Participants in the study will lie on the Caylis Pro® mattress system, which provides pulsation therapy to help distribute pressure evenly across the body. Researchers will measure how the mattress affects pressure points and blood flow by comparing different settings on the mattress. The study does not involve taking any medications or undergoing medical procedures, focusing instead on observing the natural responses of the body to the mattress. This research aims to enhance the effectiveness and comfort of mattress systems used in caring for individuals with limited mobility.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.20 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 85 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Study Objectives
Primary Objectives